News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LaBella Nicholas A. Jr.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/14/2022 |
4
| LaBella Nicholas A. Jr. (Chief Scientific Officer) has filed a Form 4 on ZyVersa Therapeutics, Inc.|
Txns:
| Granted 18,094 shares
@ $0
Granted 19,854 options to buy
@ $5.03, valued at
$99.9k
Granted 39,709 options to buy
@ $5.03, valued at
$199.7k
Granted 59,563 options to buy
@ $5.03, valued at
$299.6k
Granted 39,708 options to buy
@ $11.58, valued at
$459.8k
Granted 29,781 options to buy
@ $16.36, valued at
$487.2k
Granted 18,094 warrants
@ $6.9, valued at
$124.8k
|
|
| 12/23/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/01/2011 |
4
| LaBella Nicholas A. Jr. (Chief Scientific Officer) has filed a Form 4 on INSMED INC|
Txns:
| Granted 248,000 options to buy
@ $0.59, valued at
$146.3k
Granted 434,000 restricted stock units
@ $0 |
|
|
|